- Potent high affinity ATP-competitive inhibitor of casein kinase II (CK2) (IC50=0.13µM). Inhibits CK2 in rat liver with >1000-fold greater selectivity for CK2 than for CK1 (IC50=140nM and >200 μM, respectively).
- DYRK1A and DYRK2 inhibitor (IC50= ~0.4µM for both).
- Shown to inhibit additional kinases, such as PIM1, PIM3, HIPK2, HIPK3, PKD1 and CDK2 in the submicromolar range.
- Anticancer agent. Apoptosis inducer in different cancer cell lines.
- Induces reactive oxygen species (ROS) and DNA double strand breaks in tumor cells.
- Induces apoptosis in cells expressing an inhibitor-resistant CK2, by inhibiting quinone reductase 2 (NQO2), binding with similar affinities to the oxidized and reduced forms of NQO2.
- Useful for in vivo studies due to cell permeability and high efficacy in cultured cells and implications in research and treatment of neoplasia and infective diseases, in which CK2 plays a role.
>>> 更多资讯详情请访问蚂蚁淘商城